FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316289815> ?p ?o ?g. }

• W2316289815 abstract "Objective: Report the frequency of metabolic syndrome (MS) in newly-diagnosed glioblastoma (NGBM) patients and impact of MS on patient survival. Background The MS is a well-established risk factor for atherosclerotic cardiovascular and cerebrovascular disease. It has been identified as a risk factor for some systemic cancers and as a predictor of worse clinical outcome in systemic cancer. There is limited evidence for obesity and hyperglycemia as predictors of poor outcome in malignant glioma patients (Chambless 2011). The frequency of MS and its impact on survival of NGBM patients has not been determined. Design/Methods: We retrospectively reviewed records of all patients (N = 114) with NGBM at University Hospitals Case Medical Center from 2007-2011. Criteria for MS included > 3 of elevated fasting glucose, hypertension, elevated triglycerides, reduced high density lipoprotein C (or history of these or history of treatment for them), and obesity. The criteria had to be present prior to diagnosis of GBM. Results: MS was identified in 44/114 patients (39%). Mean patient age was 65 years (67 with MS, 64 without MS). The majority received radiation, typically with temozolomide. Median survival by MS status was 7 months for those with MS and 12 months for those without MS (p = 0.0456). After adjustment for other prognostic factors, median survival was shorter for those with MS (8 months) versus those without (10 months), but this did not reach statistical significance (p > 0.05). Conclusions: MS was identified in 39% of NGBM. The presence of MS was associated with an unadjusted lower median survival compared to patients without MS. After adjustment for independent prognostic factors, this survival difference was not significant. Because of potential limitations due to the retrospective design of this study, we will perform a prospective study to determine the impact of MS on survival of NGBM patients. Disclosure: Dr. Rogers has received personal compensation for activities with Sigma Tau Pharmaceuticals as a speaker. Dr. Vengoechea has nothing to disclose. Dr. Ostrom has nothing to disclose. Dr. Chen has nothing to disclose. Dr. Davitkov has nothing to disclose. Dr. Strodtbeck has nothing to disclose. Dr. Selman has nothing to disclose. Dr. Gerson has nothing to disclose. Dr. Nock has nothing to disclose. Dr. Machtay has nothing to disclose. Dr. Lo has nothing to disclose. Dr. Sloan has received personal compensation for activities with RealBio and Nanotech Solutions. Dr. Sloan has received research support from the NIH, Lentigen, RealBio, Nantech, Genentech, the Cristal Chair, and the Kimble Foundation. Dr. Barnholtz-Sloan has nothing to disclose." @default.
• W2316289815 created "2016-06-24" @default.
• W2316289815 creator A5001104767 @default.
• W2316289815 creator A5003243219 @default.
• W2316289815 creator A5003298368 @default.
• W2316289815 creator A5004343685 @default.
• W2316289815 creator A5008870343 @default.
• W2316289815 creator A5014071257 @default.
• W2316289815 creator A5019470085 @default.
• W2316289815 creator A5032784685 @default.
• W2316289815 creator A5042195379 @default.
• W2316289815 creator A5051948022 @default.
• W2316289815 creator A5064831934 @default.
• W2316289815 creator A5071137560 @default.
• W2316289815 creator A5089511408 @default.
• W2316289815 date "2012-04-22" @default.
• W2316289815 modified "2023-09-28" @default.
• W2316289815 title "Frequency of the Metabolic Syndrome and Association with Survival in Newly Diagnosed GBM Patients: A Retrospective Review (P07.106)" @default.
• W2316289815 doi "https://doi.org/10.1212/wnl.78.1_meetingabstracts.p07.106" @default.
• W2316289815 hasPublicationYear "2012" @default.
• W2316289815 type Work @default.
• W2316289815 sameAs 2316289815 @default.
• W2316289815 citedByCount "0" @default.
• W2316289815 crossrefType "journal-article" @default.
• W2316289815 hasAuthorship W2316289815A5001104767 @default.
• W2316289815 hasAuthorship W2316289815A5003243219 @default.
• W2316289815 hasAuthorship W2316289815A5003298368 @default.
• W2316289815 hasAuthorship W2316289815A5004343685 @default.
• W2316289815 hasAuthorship W2316289815A5008870343 @default.
• W2316289815 hasAuthorship W2316289815A5014071257 @default.
• W2316289815 hasAuthorship W2316289815A5019470085 @default.
• W2316289815 hasAuthorship W2316289815A5032784685 @default.
• W2316289815 hasAuthorship W2316289815A5042195379 @default.
• W2316289815 hasAuthorship W2316289815A5051948022 @default.
• W2316289815 hasAuthorship W2316289815A5064831934 @default.
• W2316289815 hasAuthorship W2316289815A5071137560 @default.
• W2316289815 hasAuthorship W2316289815A5089511408 @default.
• W2316289815 hasConcept C126322002 @default.
• W2316289815 hasConcept C126838900 @default.
• W2316289815 hasConcept C134018914 @default.
• W2316289815 hasConcept C143409427 @default.
• W2316289815 hasConcept C167135981 @default.
• W2316289815 hasConcept C187382586 @default.
• W2316289815 hasConcept C195910791 @default.
• W2316289815 hasConcept C2777389519 @default.
• W2316289815 hasConcept C2778227246 @default.
• W2316289815 hasConcept C2780578515 @default.
• W2316289815 hasConcept C502942594 @default.
• W2316289815 hasConcept C50440223 @default.
• W2316289815 hasConcept C509974204 @default.
• W2316289815 hasConcept C511355011 @default.
• W2316289815 hasConcept C555293320 @default.
• W2316289815 hasConcept C71924100 @default.
• W2316289815 hasConceptScore W2316289815C126322002 @default.
• W2316289815 hasConceptScore W2316289815C126838900 @default.
• W2316289815 hasConceptScore W2316289815C134018914 @default.
• W2316289815 hasConceptScore W2316289815C143409427 @default.
• W2316289815 hasConceptScore W2316289815C167135981 @default.
• W2316289815 hasConceptScore W2316289815C187382586 @default.
• W2316289815 hasConceptScore W2316289815C195910791 @default.
• W2316289815 hasConceptScore W2316289815C2777389519 @default.
• W2316289815 hasConceptScore W2316289815C2778227246 @default.
• W2316289815 hasConceptScore W2316289815C2780578515 @default.
• W2316289815 hasConceptScore W2316289815C502942594 @default.
• W2316289815 hasConceptScore W2316289815C50440223 @default.
• W2316289815 hasConceptScore W2316289815C509974204 @default.
• W2316289815 hasConceptScore W2316289815C511355011 @default.
• W2316289815 hasConceptScore W2316289815C555293320 @default.
• W2316289815 hasConceptScore W2316289815C71924100 @default.
• W2316289815 hasLocation W23162898151 @default.
• W2316289815 hasOpenAccess W2316289815 @default.
• W2316289815 hasPrimaryLocation W23162898151 @default.
• W2316289815 isParatext "false" @default.
• W2316289815 isRetracted "false" @default.
• W2316289815 magId "2316289815" @default.
• W2316289815 workType "article" @default.